Skip to the page

Data / Form D filings / Split Biosciences, Inc.

Split Biosciences, Inc.: Form D filings

Split Biosciences, Inc., a company in Seattle, WA, filed 2 Form D notices with the SEC between 2018 and 2019. The latest, on September 10, 2019, reports $560,000 sold of a $1 million offering to 9 investors.

Find out what Split Biosciences, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
FLUKE HALL, SUITE 304, 4000 MASON ROAD, Seattle, WA, 98195
Phone
(703) 401-6022
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2018
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1755695

The full lists. Form D filings in Washington: 1,095 rows, $54.75, or the new rows each week for $19 a month. Form D filings in other industries: 9,873 rows, $178.73, or the new rows each week for $19.10 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 10, 2019New notice$1,000,000$560,000$440,0009Aug 27, 2019sec.gov
Oct 12, 2018New notice$1,250,000$1,237,500$12,50020Sep 28, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Alexander Bengt RosenburgExecutive Officer, Director, Promoter
Charles Michael RocoExecutive Officer, Director, Promoter
Georg Friedrich David SeeligDirector

Other companies in Washington that filed recently

Every Form D from the week of Sep 9, 2019 · All recent filings in Washington · All recent Other filings

Read from SEC EDGAR. Amount sold is what Split Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.